Results 131 to 140 of about 7,610 (207)

Progression and topographic subtypes of Terrien marginal degeneration

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page 33-43, February 2026.
Abstract Purpose To report long‐term outcomes and to search for immunological and genetic risk factors in Terrien marginal degeneration (TMD). Methods Retrospective, in part prospective, hospital‐based longitudinal follow‐up study of 32 eyes of 16 Finnish patients from 2012 to 2023. Median follow‐up was 7.3 years (range, 0.3–15.2).
Minna Ruutila   +8 more
wiley   +1 more source

Etiologies of intermediate uveitis in a tertiary center: an age-oriented medical assessment? [PDF]

open access: yesJ Ophthalmic Inflamm Infect
Mansuy P   +5 more
europepmc   +1 more source

ERAP1 Allotypes 2 and 10 Differentially Regulate the Immunopeptidome of Melanocytes

open access: yesImmunology, Volume 177, Issue 2, Page 398-412, February 2026.
ERAP1 is an intracellular aminopeptidase that edits antigenic peptides to be presented by MHC class I molecules and is found in distinct functional allotypes in individuals. To investigate how different disease‐associated ERAP1 allotypes affect the cellular immunopeptidome, we generated A375 melanoma cell clones carrying either allotype 2 or allotype ...
Martha Nikopaschou   +6 more
wiley   +1 more source

Bilateral acute intermediate uveitis following intrauterine Chitosan tamponade: a case series. [PDF]

open access: yesJ Ophthalmic Inflamm Infect
Beckers D   +6 more
europepmc   +1 more source

Foreign Body Granuloma and Infection‐Related Complications Arising From Acupoint Embedding: A Case Study and Literature Review

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 2, February 2026.
ABSTRACT Background Acupoint embedding (AEM) therapy merges traditional acupuncture with modern biomaterials to treat various diseases and for cosmetic uses, especially obesity and facial anti‐aging. Research Objective To examine complications from acupuncture embedding therapy (AEM), focusing on foreign body granulomas and infections.
Xiazhen Xu   +4 more
wiley   +1 more source

Targeting alpha-4 integrin with natalizumab for intermediate uveitis associated with multiple sclerosis. [PDF]

open access: yesMult Scler J Exp Transl Clin
Calma AD   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy